Harmonic Discovery

New York, United States Founded: 2021 • Age: 5 yrs
Developer of kinase inhibitor drugs for oncology
Annual revenue - Latest available
Total funding $8.1M 2 rounds
Employees 7 Tracked headcount
Investors 5 Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About Harmonic Discovery

Harmonic Discovery is a company based in New York (United States) founded in 2021 by Rayees Rahman, Marcel Patek, and Jason Lee. Harmonic Discovery has raised $8.13 million across 2 funding rounds from investors including Innovation Endeavors, BOOM Capital and Caffeinated Capital. The company has 7 employees as of December 31, 2022. Harmonic Discovery offers products and services including Generative Chemistry Platform and Precision Pharmacology Platform. Harmonic Discovery operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.

  • Headquarter New York, United States
  • Employees 7 as on 31 Dec, 2022
  • Founders Rayees Rahman, Marcel Patek, Jason Lee
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Harmonic Discovery
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $8.13 M (USD)

    in 2 rounds

  • Latest Funding Round
    $8 M (USD), Seed

    Sep 08, 2022

  • Investors
  • Employee Count
    7

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Harmonic Discovery

Harmonic Discovery offers a comprehensive portfolio of products and services, including Generative Chemistry Platform and Precision Pharmacology Platform.

Product name locked
Category locked
Primary

Tool for predicting and tuning molecular interactions in drug development.

Product name locked
Category locked
Locked

Platform analyzing protein structures for improved therapeutic design.

People of Harmonic Discovery

Headcount 1-10
Employee Profiles 5
Employee Profiles
People
Rayees Rahman
Co-founder, CEO
People
Anna Cichonska
Director of Data Science & Head of European Operations
People
Marcel Patek
CSO and co-founder
People
Ravi Rajagopalan
Vice President, Drug Discovery & Development

Unlock access to complete

Funding Insights of Harmonic Discovery

Harmonic Discovery has successfully raised a total of $8.13M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $8 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Harmonic Discovery

Harmonic Discovery has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Innovation Endeavors, BOOM Capital and Caffeinated Capital.

All
Venture Fund
Investor Description Founded Year Domain Location
Early-stage technology investments are targeted by this venture capital firm.
Locked Locked Locked
Early investments in science-focused startups are made by BOOM Capital.
Locked Locked Locked
A venture firm based in San Francisco and New York, investments are made in technology companies.
Locked Locked Locked
Premium access

Investor details for Harmonic Discovery

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Harmonic Discovery

Investments
Premium access

Investment portfolio details for Harmonic Discovery

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Harmonic Discovery

Premium access

Detailed financials for Harmonic Discovery

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Harmonic Discovery Comparisons

Harmonic Discovery Primary company
Description
Developer of kinase inhibitor drugs for oncology
Location
New York, United States
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
7
As of 2022
Premium access

Peer comparison for Harmonic Discovery

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Harmonic Discovery

Harmonic Discovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
mRNA-based therapeutics for diseases including cancer and infections are developed.
Locked Locked Locked
Novel biopharmaceutical medicines are developed for unmet medical needs.
Locked Locked Locked
Targeted and immune-oncology drugs for cancer treatment are developed.
Locked Locked Locked
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
Locked Locked Locked
Small molecules are developed for cancer and skin disease treatments.
Locked Locked Locked
Cancer therapies are developed using selective pathway inhibitors.
Premium access

Detailed competitors of Harmonic Discovery

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Harmonic Discovery

Premium access

Complete news archive for Harmonic Discovery

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harmonic Discovery

Harmonic Discovery was founded in 2021.

Harmonic Discovery is headquartered in New York, United States. It is registered at New York, New York, United States.

Rayees Rahman is the current CEO of Harmonic Discovery. They have also founded this company.

Harmonic Discovery is a funded company, having raised a total of $8.13M across 2 funding rounds to date.

As of Dec 31, 2022, the latest employee count at Harmonic Discovery is 7.

Founded in 2021 and based in New York, United States, Harmonic Discovery operates in the oncology sector. Kinase inhibitor drugs are developed by the company through a platform that combines biological screening, medicinal chemistry, and computational methods. Clinical resistance mutations are predicted, and small molecule therapeutics are optimized to sustain target binding while minimizing off-target effects, supporting cancer treatment strategies.

Harmonic Discovery's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.

Harmonic Discovery offers Generative Chemistry Platform and Precision Pharmacology Platform.

Harmonic Discovery has 5 investors. Key investors include Innovation Endeavors, BOOM Capital, Caffeinated Capital, Fifty Years, and Y Combinator.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available